Brief: Eql Pharma's Rights Issue Subscribed To Approximately 161.7 Percent
EQL Pharma AB EQL.TE :
* EQL PHARMA'S RIGHTS ISSUE SUBSCRIBED TO APPROXIMATELY
161.7
PERCENT
* RIGHTS ISSUE RAISES PROCEEDS OF APPROXIMATELY MSEK 24.9
BEFORE
ISSUE COSTS OF APPROXIMATELY MSEK 1.7.
Source text for Eikon: ID:nWkr9tb44x
Further company coverage: EQL.TE